A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin
暂无分享,去创建一个
T. Waldmann | I. Pastan | V. Chaudhary | R. Junghans | G. Queen | D. FitzGerald | Thomas A. Waldmann
[1] I. Pastan,et al. Cytotoxic activity of an interleukin 6-Pseudomonas exotoxin fusion protein on human myeloma cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[2] K. D. Hardman,et al. Single-chain antigen-binding proteins. , 1988, Science.
[3] I. Pastan,et al. Selective killing of HIV-infected cells by recombinant human CD4-Pseudomonas exotoxin hybrid protein , 1988, Nature.
[4] R. Bruccoleri,et al. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[5] I. Pastan,et al. Activity of immunotoxins constructed with modified Pseudomonas exotoxin A lacking the cell recognition domain. , 1988, The Journal of biological chemistry.
[6] I. Pastan,et al. Cytotoxic activity of an interleukin 2-Pseudomonas exotoxin chimeric protein produced in Escherichia coli. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[7] E. Vitetta,et al. Redesigning nature's poisons to create anti-tumor reagents. , 1987, Science.
[8] I. Pastan,et al. Activity of a recombinant fusion protein between transforming growth factor type alpha and Pseudomonas toxin. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[9] I. Pastan,et al. Pseudomonas exotoxin coupled to a monoclonal antibody against ovarian cancer inhibits the growth of human ovarian cancer cells in a mouse model. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[10] I. Pastan,et al. Functional domains of pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli , 1987, Cell.
[11] F. Studier,et al. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. , 1986, Journal of molecular biology.
[12] W. Greene,et al. Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen , 1984, The Journal of experimental medicine.
[13] T. Waldmann,et al. Pseudomonas exotoxin-anti-TAC. Cell-specific immunotoxin active against cells expressing the human T cell growth factor receptor. , 1984, The Journal of clinical investigation.
[14] S. Salahuddin,et al. Restricted expression of human T-cell leukemia--lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. , 1983, Virology.
[15] A. Schechter,et al. The concepts of crossreactivity and specificity in immunology. , 1981, Molecular immunology.
[16] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[17] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.